A1 |
Assessments including clinical measures and participant-reported outcomes completed before SPA |
A2 |
Assessments including clinical measures and participant-reported outcomes completed after SPA |
A3 |
Assessments including clinical measures and participant-reported outcomes completed before SPC |
A4 |
Assessments including clinical measures and participant-reported outcomes completed after SPC |
AE |
Adverse events |
CP |
Cerebral palsy |
GOAL |
Gait Outcomes Assessment List |
ICF-CY |
International Classification of Functioning, Disability and Health-Children and Youth Version |
MDCs95 |
Minimal detectable change 95% confidence level |
MRC |
Medical Research Council |
MWS |
Maximum walking speed |
(f) rNMS |
(Functional) repetitive neuromuscular magnetic stimulation |
SCALE |
Selective Control Assessment of Lower Extremity |
SD |
Standard deviation |
SPA |
Study period A |
SPC |
Study period C |
SSWS |
Self-selected walking speed |
UMNS |
Upper motor neuron syndrome |
10 MWT |
10 Meter Walking Test |